Classical swine fever virus (CSFV) protects cells from double-stranded (ds) RNA-mediated apoptosis and IFN-a/h induction. This phenotype is lost when CSFV lacks N pro (DN pro CSFV). In the present study, we demonstrate that N pro counteracts dsRNA-mediated apoptosis and IFN-a/h induction independently of other CSFV elements. For this purpose, we generated porcine SK-6 and PK-15 cell lines constitutively expressing N pro fused to the enhanced green fluorescent protein (EGFP). The survival of the SK6-EGFP-N pro cell line after polyinosinic polycytidylic acid [poly(IC)] treatment was comparable to that of CSFV-infected SK-6 cells and was significantly higher than the survival of the parent cell line. In PK-15 cells, the presence of EGFP-N pro prevented the DN pro CSFV-and poly(IC)-mediated IFN-a/h production. Importantly, N pro also inhibited IFN-a and IFN-h promoter-driven luciferase expression in human cells and blocked IFN-a/h induction mediated by Newcastle disease virus. This establishes a novel function for N pro in counteraction of the IFN-a/h induction pathway. D
Introduction
Classical swine fever virus (CSFV) is the causative agent of classical swine fever, a severe hemorrhagic disease of pigs. CSFV together with bovine viral diarrhea virus (BVDV) and border disease virus (BDV) belongs to the genus Pestivirus within the Flaviviridae family. The other members of the Flaviviridae are the genera Flavivirus and Hepacivirus that represent important human pathogens (vanRegenmortel et al., 2000) . Pestiviruses carry an RNA genome of positive polarity that possesses a 5V untranslated region (5VUTR), a single open reading frame (ORF) and a 3VUTR. The 5VUTR functions as an internal ribosomal entry site (IRES) for cap-independent translation initiation of the large ORF that is co-and posttranslationally processed into twelve mature proteins by viral and host cell proteases (for review, see Meyers and Thiel, 1996) .
The first protein encoded by the ORF is the nonstructural protein N pro . The only established function of N pro is its autoproteolytical activity that allows cleavage from the downstream nucleocapsid protein C (Rumenapf et al., 1998; Stark et al., 1993; Wiskerchen et al., 1991) . Interestingly, N pro is unique to the pestiviruses within the Flaviviridae family and was found to be dispensable for virus replication in cell culture (Lai et al., 2000; Tratschin et al., 1998) . The N pro gene of the moderately virulent strain vA187-1 and the highly virulent strain vEy-37 was deleted or replaced with the murine ubiquitin gene that substitutes for N pro in the generation of the authentic nucleocapsid protein. displayed no major alteration of growth characteristics in the porcine kidney cell line SK-6 but were avirulent in pigs (Mayer et al., 2004; Tratschin et al., 1998) . Deletion of viral genes or mutations that did not abolish virus replication in cell culture but resulted in attenuation in the immunecompetent host led to the discovery of various mechanisms acquired by viruses during evolution to subvert the host defense, in particular the interferon system (for recent reviews, see Basler and Garcia-Sastre, 2002; Goodbourn et al., 2000; Weber et al., 2004) . For the pestiviruses, it is now well established that virus replication interferes with cellular antiviral defense (Baigent et al., 2002; Bensaude et al., 2004; Carrasco et al., 2004; La Rocca et al., 2005; Ruggli et al., 2003; Schweizer and Peterhans, 2001) . Our recent data with DN pro CSFV showed that N pro was required by CSFV to prevent double-stranded (ds) RNA-mediated apoptosis in SK-6 cells and IFN-a/h induction in macrophages (Ruggli et al., 2003) . Furthermore, as opposed to wild-type CSFV, DN pro CSFV induced IFN-a/h independently of exogenous dsRNA stimulation, suggesting a role for N pro in the counteraction of IFN-a/h induction. However, the latter data did not exclude the requirement of other CSFV elements in conjunction with N pro . Very recently, it was shown that N pro of BVDV was partly responsible for blocking interferon regulatory factor (IRF)3-dependent transcription (Horscroft et al., 2005) . Furthermore, while this manuscript was under revision, N pro was shown to be involved in transcriptional inhibition of IRF3 (La Rocca et al., 2005) . In addition, a recent report suggested a role of BVDV E rns in the control of IFN-a/h induction (Iqbal et al., 2004) . In the present study, we demonstrate that N pro of CSFV is capable of preventing polyinosinic polycytidylic acid [poly(IC)]-and Newcastle disease virus (NDV)-mediated IFN-a/h induction, independently of the CSFV context. These data clearly establish a novel function for N pro in interference with the induction of IFN-a/h.
Results
Establishment of porcine SK-6 and PK-15 cell lines expressing the enhanced green fluorescent protein (EGFP)-N pro fusion protein or EGFP alone
When treated with poly(IC), SK-6 cells undergo apoptosis but do not produce any detectable IFN-a/h. In contrast, PK-15 cells tolerate higher poly(IC) concentrations in the cell culture supernatant and respond to poly(IC) transfection with IFN-a/h production. Infection with CSFV, as opposed to CSFV lacking the N pro gene, prevents these cellular responses, suggesting that N pro is an antagonist of cellular antiviral defense (Ruggli et al., 2003) . In order to study the function of N pro independently of other CSFV elements, we established stable clonal SK-6 and PK-15 porcine kidney cell lines expressing N pro in fusion with EGFP under the control of the human cytomegalovirus (CMV) immediate early promoter. Control cell lines expressing EGFP alone were generated in order to exclude a non-specific effect due to expression of a foreign protein. After repeated end point dilution, we obtained stable SK-6 and PK-15 clones expressing the EGFP-N pro fusion protein (SK6-EGFP-N pro , PK15-EGFP-N pro ) or EGFP alone (SK6-EGFP, PK15-EGFP). Two independent cell clones were selected for each type of stable transformant. As expected, a 46 kDa protein was detected for the EGFP-N pro expressing cells with both the anti-EGFP (Fig. 1A, lanes 2 and 5) and the rabbit anti-N pro (Fig. 1B, lanes 2 and 5) antibodies. A 27 kDa protein was detected for the EGFP expressing cell lines with the anti-EGFP monoclonal antibody (mAb) (Fig. 1A, lanes 3 and  6) . For the SK-6 and PK-15 clones, the expression level of the EGFP-N pro fusion protein (46 kDa) was 10, respectively 60 times lower than the EGFP (27 kDa) expression level. Six times less EGFP-N pro fusion protein was expressed in the PK-15 clones when compared with the SK-6 clones. The result shown in Fig. 1 for one set of stable transformants is representative of both independent clones. Fig. 1 . Western blot analysis of EGFP-N pro and EGFP expression in stably transformed SK-6 and PK-15 cells. SK-6 and PK-15 cells were transfected with linearized expression plasmid and selected for G418 resistance. Single colonies of stably transformed clones expressing EGFP-N pro fusion protein (46 kDa) or EGFP alone (27 kDa) were picked and purified by several rounds of end point dilution. Equivalent amounts of protein extract (5 Ag/ lane) from the cloned cell lines were separated by SDS-PAGE and analyzed by Western blotting using mAb JL-8 directed against EGFP (A) and a rabbit antiserum raised against N pro (B The EGFP-N pro fusion does not alter the capacity of CSFV to prevent poly(IC)-mediated apoptosis and IFN-a/b induction The use of EGFP-N pro fusion for the analysis of the IFN-a/h antagonistic function of N pro was first evaluated in the virus context. For this purpose, the N pro gene of the full-length cDNA clone pA187-1 was replaced by the EGFP-N pro fusion cassette of the expression plasmid pCMV-EGFP-N pro . Because the RNA secondary structure immediately downstream of the start codon is critical for translation initiation of pestivirus RNA (Fletcher et al., 2002; Myers et al., 2001) , we inserted the sequence coding for the murine ubiquitin gene between the 5VUTR and the EGFP gene. The expression level of the EGFP-N pro fusion protein from the cDNA-derived virus vA187-Ub-EGFP-N pro was 30 times lower when compared with N pro expression from the vA187-1 parent virus ( Fig. 2A) . However, PK-15 cells infected with vA187-Ub-EGFP-N pro were resistant to poly(IC)-mediated IFN-a/h induction to the same extent as vA187-1-infected cells, whereas poly(IC) transfection induced IFN-a/h in vA187-DN pro -and mock-infected PK-15 cells (Figs. 2B and D, dark gray bars). The two times higher IFN-a/h expression in mock-versus vA187-DN pro -infected cells (Fig. 2B ) was statistically significant ( P < 0.001, n = 3, t test). The vA187-Ub-EGFP-N pro -and vA187-1-mediated block of IFN-h induction was at the level of mRNA (Figs. 2C and D) . In absence of poly(IC) transfection, vA187-DN pro induced IFNa/h in PK-15 cells as previously observed, whereas no IFNa/h expression was detected upon infection with vA187-Ub-EGFP-N pro and vA187-1, both when bioactivity and IFN-h mRNA were analyzed (Figs. 2B and C, light gray bars). The difference in the level of IFN-h mRNA upregulation observed 20 h post-treatment for vA187-DN pro -infected ( Fig. 2C ) versus poly(IC)-transfected cells (Fig. 2D ) might reflect a difference in the kinetics of induction by the two stimuli. This was not further investigated. In SK-6 cells, vA187-Ub-EGFP-N pro prevented poly(IC)-mediated apoptosis as measured in the cell survival assay (data not shown). Taken together, these data show that CSFV expressing the EGFP-N pro fusion protein prevents poly(IC)-mediated apoptosis and IFN-a/h induction to the same extent as the parent vA187-1 virus. This validates the use of the stable cell lines expressing N pro fused to EGFP to investigate whether N pro is capable of conferring resistance to poly(IC)-mediated apoptosis and to dsRNA-and virus-mediated IFN-a/h induction, independently of other CSFV elements.
Expression of EGFP-N
pro protects SK-6 cells from dsRNA-mediated apoptosis
We have shown previously that SK-6 cells infected with CSFV survived in the presence of higher concentrations of poly(IC) than SK-6 cells infected with CSFV lacking the N pro gene or mock-infected cells (Ruggli et al., 2003) . Although the mechanism of pestivirus-mediated resistance to poly(IC) has yet to be elucidated, we analyzed whether this phenotype could be attributed to N pro alone by using constitutive expression of EGFP-N pro in SK-6 cells (Fig. 3) . The cell line expressing the EGFP-N pro fusion protein had a survival rate comparable to that of CSFV vA187-1-infected cells. The percentage of surviving SK6-EGFP-N pro cells was significantly higher than the survival rate observed with mock-infected cells or with cells infected with DN pro CSFV ( P < 0.01, n = 9, t test). The two cell lines expressing the proteins E2p7 of CSFV or EGFP were highly susceptible to treatment with poly(IC). For the SK6-EGFP-N pro cells, the degree of foreign protein expression was lower than for the SK6-EGFP cells ( Fig. 1 ) but was comparable to that of the SK6-E2p7 cells (data not shown). Thus, we can conclude that the increased survival rate to poly(IC) observed with CSFV-infected cells can be mediated by N pro independently of other CSFV elements and that this phenotype represents a significant gain of function when compared with the parent SK-6 cell line or with the SK-6 cells expressing EGFP alone. infected cells (Fig. 4D, lane 3) and completely restored the phenotype of vA187-1, resulting in absence of IFN-a/h induction. Next, we asked whether N pro was capable of blocking IFN-a/h induction independently of other CSFV elements. For this purpose, we stimulated the stably transformed cell lines with poly(IC) for IFN-a/h production. After poly(IC) transfection, no IFN-a/h bioactivity was detected in any of the N pro expressing PK-15 cell lines, demonstrating that N pro alone was capable of blocking dsRNA-mediated IFN-a/h induction in the absence of the viral context. At the level of bioactivity, no significant difference was observed between both independent clones of each type (Fig. 4B) . Quantitative reverse transcription (RT)-PCR for IFN-h mRNA after poly(IC) stimulation demonstrated that N pro was capable of inhibiting IFN-h induction at the mRNA level (Fig. 4C ). More sensitive than bioactivity detection, the quantitative RT-PCR revealed a low level of IFN-h mRNA induction in one of the PK15-EGFP-N pro cell lines (Fig. 4C , PK15-EGFP-N pro #2). This latter experiment was performed after multiple passages of the PK15-EGFP-N pro clones. The IFN-h mRNA upregulation in one of the two clones might reflect a loss of N pro expression in a low percentage of cells. IFN-a/h bioactivity in these cell culture supernatants was not analyzed. No porcine IFN-a1 mRNA upregulation was detected in PK15-EGFP clones or in the PK-15 cells (data not shown). Accordingly, IFN-a/h bioactivity could not be neutralized from the supernatant of these cells using an anti-pig IFN-a serum (data not shown). The results obtained above with stably transformed PK-15 cells demonstrate that N pro prevents IFN-h induction independently of other CSFV elements by blocking IFN-h mRNA upregulation. Using an independent approach, we investigated the effect of transient expression of N pro and various control proteins on the poly(IC)-mediated induction of both the human IFN-a and IFN-h promoter. For this purpose, we utilized established firefly luciferase reporter gene assays for human IFN-a and IFN-h promoter activity in HEK293T cells, using plasmids paLuc and p125Luc, respectively (Yoneyama et al., 1996) . The proteins N pro , EGFP-N pro , C (Core), E rns and E2p7 of CSFV, NSs of Bunyamwera virus (BUNV) and EGFP were transiently expressed under the control of either the CMV promoter or the elongation factor 1a promoter (pEAK8-derived plasmids). Protein expression was confirmed by in situ immunostaining and by Western blotting (data not shown). Two independent promoters were chosen to reduce the possibility of artifacts due to cross talk with the IFN-a and IFN-h promoters. The inducible firefly luciferase expression was normalized with constitutive expression of Renilla luciferase using phRL-SV40 (Promega) according to Materials and methods. Similar results were obtained with paLuc ( Fig. 5A) and p125Luc (Fig. 5B) . In the presence of the empty expression vectors and the vectors expressing EGFP, CSFV C and E2p7 proteins, poly(IC) transfection resulted in a 3-to 5-fold induction of normalized firefly luciferase expression relative to mock transfection. Interestingly, when E rns was expressed, a slightly reduced IFN-a promoter induction was observed whereas the IFN-h promoter induction was not affected. With N pro alone or in fusion with EGFP, as well as with BUNV NSs, the poly(IC)-induced IFN-a and IFN-h promoter-driven firefly luciferase expression was reduced to 1-fold induction relative to mock stimulation. The inductions measured in presence of the N pro and BUNV NSs expressing plasmids were compared pairwise in the t test with the inductions obtained in presence of the plasmids expressing various other proteins or of the empty vectors. The differences were all statistically significant ( P < 0.05, n = 3 for the IFN-a promoter and n = 6 for the IFN-h promoter). These data confirm the results obtained with the stably transformed PK-15 cells and demonstrate that N pro of CSFV prevents dsRNA-mediated upregulation of IFN-a/h mRNA transcription to the same extent as BUNV NSs. This function is specific to N pro expression since C, E rns , E2p7 and EGFP expression as well as the empty expression vectors do not significantly impair the activation of IFN-a/h promoters under the conditions analyzed.
EGFP-N pro prevents NDV-mediated IFN-b induction
A well-established property of pestiviruses is the enhancement of Newcastle disease virus replication, also called END (Inaba et al., 1963; Kumagai et al., 1958) . The END phenotype was related to suppression of IFN-a/h production by pestiviruses (Diderholm and Dinter, 1966; Toba and Matumoto, 1969) . Therefore, we asked the question whether N pro of CSFV was responsible for the END phenotype and was capable of suppressing NDV-induced IFN-a/h production in PK-15 cells independently of other CSFV elements. For this purpose, the PK-15 clones expressing either EGFP-N pro or EGFP alone were infected with NDV at a multiplicity of infection of 0.1 50% tissue culture infectious dose (TCID 50 )/cell. IFN-h mRNA upregulation was detected only in PK15-EGFP clones and in the PK-15 cell line but not in the PK15-EGFP-N pro clones (Fig. 6 ). IFN-a/h bioactivity in the supernatant of NDV-infected PK-15 cells could not be measured because of the high susceptibility of the MDBKt2 cells to NDV that could only be partially neutralized or inactivated. Nevertheless, these experiments show that N pro of CSFV can suppress IFN-h induction mediated by an unrelated virus such as NDV.
Discussion
The presence of the N pro gene is a feature that distinguishes the pestivirus genus from the other genera of the Flaviviridae family (for review, see Lindenbach and Rice, 2001) . Autoproteolysis was the first established function of N pro (Rumenapf et al., 1998; Stark et al., 1993; Wiskerchen et al., 1991) . Although N pro was found to be dispensable for pestivirus replication in cell culture (Lai et al., 2000; Tratschin et al., 1998) , this gene has been maintained during evolution, and its deletion resulted in strong attenuation of the virus in pigs (Mayer et al., 2004) . These observations led to the hypothesis that additional functions of N pro would confer advantage to the virus in its natural host. Recently, we obtained strong evidence that N pro was involved in the interference of CSFV with cellular antiviral defense mechanisms. The absence of N pro correlated with the loss of the capacity of the virus to interfere with dsRNA-mediated apoptosis and IFN-a/h induction (Ruggli et al., 2003) . To demonstrate that N pro was by itself responsible for this interference, we established stable cell lines expressing N pro in fusion with EGFP. This approach allowed the use of control cell lines expressing the EGFP fusion partner alone to exclude effects due to expression of a foreign protein.
In order to use the EGFP-N pro fusion protein to analyze the function of N pro independently of the virus, it was necessary to demonstrate that the fusion with EGFP did not alter the function of N pro in the viral context. The experiments shown in Fig. 2 indicate that EGFP-N pro levels far below wild-type amounts of N pro are sufficient to mediate complete block of poly(IC)-mediated IFN-a/h induction. Interestingly, poly(IC) induced twice as much IFN-a/h bioactivity in mock versus DN pro CSFV-infected cells (Fig.  2B) . This difference might indicate the presence of additional CSFV elements that might modulate the IFN-a/h induction pathways. One candidate is the E rns protein that was shown for BVDV to specifically inactivate dsRNAdependent signaling events when expressed in cells or added exogenously to the cell culture medium (Iqbal et al., 2004) . Results from our reporter assays for IFN-a and IFN-h promoter activity in HEK293T cells however suggest that E rns expression does not prevent IFN-a/h induction from an intracellular dsRNA stimulus. E rns of CSFV is found in secreted form in the supernatant of infected cells and possesses RNase activity (Hulst et al., 1994; Schneider et al., 1993 (Figs. 2C and D) . In PK-15 cells, the IFN-a/h bioactivity could not be blocked with anti-pig IFN-a serum, and no IFN-a1 mRNA upregulation could be detected (data not shown). This indicates that the discrepancy between IFN-h mRNA and IFN-a/h bioactivity observed in these experiments is most probably not due to differential activation of IFN-h and IFN-a but is rather due to the kinetics of induction.
Although we do not yet understand the mechanisms behind the enhanced resistance of CSFV-infected SK-6 cells to apoptosis induced by poly(IC), we demonstrate here that the expression of EGFP-N pro independently of the virus confers at least as good protection as infection with vA187-1. Key players in the induction of dsRNA-mediated apoptosis are the dsRNA-dependent protein kinase (PKR) and the coupled 2V-5V oligoadenylate synthetase (2 -5 OAS)/RNaseL system (for reviews, see Gil and Esteban, 2000; Player and Torrence, 1998; Samuel, 2001 ). PKR might be directly targeted by N pro or its activation may be inhibited indirectly through sequestration of dsRNA. These potential mechanisms have been described for various viral systems (for review, see Gale and Katze, 1998) . Whether N pro of CSFV has dsRNA binding activity is currently under investigation.
Besides being an inducer of apoptosis, it is well established that dsRNA is a potent activator of IFN-a/h production (Goodbourn et al., 2000; Jacobs and Langland, 1996) . With cytopathogenic CSFV, we found a strong correlation between the amount of CSFV dsRNA and the IFN-a/h induction capacity of the virus and demonstrated that N pro modulated this induction (Bauhofer et al., unpublished) . Transfection experiments indicated that IFNa/h induction was specific for in vitro synthesized CSFV dsRNA but not for non-replicating CSFV ssRNA (Bauhofer et al., unpublished) . The cellular receptors for CSFV dsRNA are unknown. Potential candidates are the toll-like receptors (TLR) (for selected reviews, see Boehme and Compton, 2004; Finberg and KurtJones, 2004; Rassa and Ross, 2003) and the helicases retinoic acid inducible gene I (RIG-I) product (Yoneyama et al., 2004) and melanoma differentiation-associated gene 5 (mda-5) product (Andrejeva et al., 2004; Kang et al., 2002) . All these pathways induce phosphorylation of IRF3. For noncytopathogenic and cytopathogenic BVDV, it was shown that IRF3 but not IRF7 was phosphorylated and translocated to the nucleus in response to virus infection, but IRF3 binding to cellular DNA was not observed (Baigent et al., 2002 (Baigent et al., , 2004 . For CSFV, La Rocca and coworkers suggested that CSFV did not provide an effective signal for nuclear translocation of IRF3 and that N pro inhibited expression of IRF3 at the transcriptional level (La Rocca et al., 2005) . These two reports indicate that N pro of BVDV and CSFV may interfere at different levels in the IFN-a/h induction pathway. Furthermore, a recent report showed that N pro of BVDV partly interfered with IRF3-dependent pathways (Horscroft et al., 2005) . We used NSs of Bunyamwera virus as control protein for the inhibition of IFN-a and IFN-h induction in the transient reporter assays. This protein was shown to act downstream of IRF3 activation by inhibiting the phosphorylation of the large subunit of cellular RNA polymerase II (Thomas et al., 2004) .
The interferences observed with CSFV in the viral context, i.e. resistance to poly(IC)-mediated apoptosis and prevention of IFN-a/h induction after stimulation with either poly(IC) or NDV, could be reproduced with N pro alone. Thus, N pro certainly represents the molecular basis for the enhancement of NDV replication by pestiviruses called END phenotype and recognized a long time ago to be due to the virusmediated prevention of IFN-a/h induction (Diderholm and Dinter, 1966; Toba and Matumoto, 1969) . The observation that N pro can act independently of CSFV does not exclude the possibility that additional CSFV elements might exert a similar function and act synergistically in the same or other cell types of the host. As mentioned above, a role of E rns in this context has been suggested for BVDV (Iqbal et al., 2004) and needs further investigation. The block of IFN-a/h synthesis is one of various strategies evolved by viruses to fight the interferon system (for reviews, see Goodbourn et al., 2000; Weber et al., 2004) . It is increasingly clear that this strategy has also evolved in pestiviruses (Baigent et al., 2002; Bensaude et al., 2004; Carrasco et al., 2004; Ruggli et al., 2003; Schweizer and Peterhans, 2001) , and N pro is a key player in this context (Horscroft et al., 2005; La Rocca et al., 2005; Ruggli et al., 2003) . Whether this novel function of N pro depends on the proteinase activity or on other structural elements of N pro or both is under current investigation. The fact that N pro is also a functional antagonist of IFN-a/h mRNA upregulation in human cells opens a wide range of possibilities to analyze the pathways involved. There is no evidence yet for major interference of pestiviruses with IFNa/h signaling and effector pathways (Peterhans et al., 2003; Schweizer and Peterhans, 2001 ). For BVDV, it was shown that the IFN-stimulated MxA biosynthesis was not compromised in noncytopathogenic BVDV-infected cells (Baigent et al., 2002) . This is in contrast with other Flaviviridae (Diamond, 2003) and with the closely related HCV that interfere with IFN signaling (for review, see Macdonald and Harris, 2004; Tan and Katze, 2001 ). More detailed understanding of the mechanisms of how N pro interferes with the IFN-a/h induction pathways and affects virus replication in vivo is expected to shed more light on the pathogenesis of classical swine fever.
Materials and methods

Cells and viruses
The porcine kidney cell line SK-6 (Kasza et al., 1972) was obtained from M. Pensaert (Faculty of Veterinary Medicine, Ghent, Belgium) and was propagated in Earle's minimum essential medium (EMEM) supplemented with 7% horse serum. The porcine kidney cell line PK-15 (American Type Culture Collection, Manassas, VA, USA) was maintained in Dulbecco's minimum essential medium supplemented with 5% horse serum. HEK293T cells were propagated in EMEM supplemented with 7% fetal bovine serum (Biochrom AG, Switzerland). The MDBK-t2 cell line was kindly provided by Martin D. Fray (Institute of Animal Health, Compton, Newbury, Berkshire, UK) and maintained in EMEM supplemented with 7% fetal bovine serum and 10 Ag/ml blasticidin (Invitrogen). CSFV strains vA187-1 and vA187-DN pro were derived from the full-length cDNA clones pA187-1 (Ruggli et al., 1996) and pA187-DN pro (Ruggli et al., 2003) , respectively. CSFV vA187-Ub-EGFP-N pro was rescued from pA187-Ub-EGFP-N pro , a full-length cDNA clone in which a cassette encoding the murine ubiquitin, the EGFP and a GlyGly -Ser -Gly -Gly -Ser peptide linker, was inserted between the 5VUTR and the N pro gene of pA187-1 (details of the construction can be obtained on request). All cDNAderived viruses were rescued by electroporation of SK-6 cells with the respective in vitro transcripts as described elsewhere (Moser et al., 1999) . NDV strain Hitchner B1 was obtained from Lohmann AG (Cuxhaven, Germany) and passaged once on specific pathogen-free eggs resulting in a titer of 10 6.5 TCID 50 /ml on PK-15 cells.
Plasmids
The reporter plasmids paLuc and p125Luc expressing firefly luciferase under the control of human IFN-a and IFN-h promoter elements respectively were a gift of Takashi Fujita (Yoneyama et al., 1996) . Plasmid phRL-SV40 (Promega) constitutively expressing Renilla luciferase was used for internal normalization of inducible firefly luciferase. The three expression plasmids pEGFP-N1 (Clontech), pEAK8-His derived from pEAK8 (Edge BioSystems) as described elsewhere (Balmelli et al., 2005) and pCI-Neo (Promega) were used to express the proteins N pro , C and E2p7 of CSFV Alfort/187. The respective CSFV genes were derived from the full-length cDNA clone pA187-1 (Ruggli et al., 1996) and engineered into the expression plasmids by standard cloning technique using PCR with PfuTurbo DNA polymerase (Stratagene). For the construction of pCMV-EGFP-N pro , the N pro gene was amplified with the sense primer Bsr-GS-NproL (5V-GAGCTGTACAAGGGCG-GAAGCGGAGGCAGCATGGAGTTGAATCATTTT-GAACT-3V, containing the 3V end of the EGFP gene including the restriction site BsrGI but lacking the stop codon followed by a sequence encoding a Gly-Gly -SerGly -Gly -Ser peptide linker and by the 5V-terminal sequence of the N pro gene) and with the antisense primer N-st-NproR (5V-ATATAGCTGCGGCCGCTAATTAAT-CAGCAACTGGTAACCCACAATGGA-3V, encoding the antisense sequence of the 3V end of the N pro gene, three stop codons and a NotI restriction site). PCR-based cloning was also used for the construction of pEAK-N pro , pEAKCore-6H, pCI-Ub-Core, and pCMVsigE rns (details can be obtained on request). The construct pCMVsigE2p7 was described elsewhere (Maurer et al., 2005) . Plasmid pCDNABUNNSs (Weber et al., 2002) kindly provided by Friedemann Weber was used to express NSs of BUNV. Plasmids were propagated in E. coli XL-1 blue (Stratagene) and purified using the NucleoBond Plasmid DNA purification system (Macherey-Nagel). All constructs were verified by DNA sequencing using the Thermo Sequenase DYEnamic direct cycle sequencing kit (Amersham Biosciences) and the Global IR 2 System and e-Seq software (LI-COR).
Selection of stably transformed cell lines
Subconfluent monolayers of SK-6 and PK-15 cells were transfected with pCMV-EGFP-N pro or with pEGFP-N1 using FuGENE 6 transfection reagent (Roche) according to the manufacturer's protocol with a 6 to 1 (v/w) FuGENE 6 to DNA ratio. The plasmid DNA was added to serum-free EMEM containing the FuGENE 6 transfection reagent. After 20 min of incubation at room temperature, the transfection mixture was added directly into the complete culture medium of the cell monolayer. After 48 h, the cell culture medium was replaced with fresh complete medium supplemented with 500 Ag/ml G418-Sulfate (CalbiochemNovabiochem Corp). Single colonies were picked and purified by two to three rounds of end point dilution. The purified clones were propagated under selection with 250 Ag/ml G418-sulfate.
Antibodies
For the detection of the viral protein N pro , a polyclonal antiserum was produced in rabbits using recombinant N pro expressed in E. coli. For this purpose, the N pro gene of CSFV strain vA187-1 was amplified from pA187-1 using the oligonucleotide B-NproL (5V-GCGAGCGGATCC-GATGGAGTTGAATCATTTTGAACT-3V) containing a BamHI site upstream of the start codon and the antisense oligonucleotide H-st-NproR (5V-CTAGCTAAGCTTAG-CAACTGGTAACCCACAATGGA-3V) coding for a stop codon and a HindIII recognition site downstream of the N pro sequence. The PCR fragment was cloned into pCR-XL-TOPO (Invitrogen), and the DNA sequence was verified by nucleotide sequencing as described above. The N pro gene was then excised with BamHI and HindIII restriction endonuclease digestion and subcloned into the BamHI and HindIII restriction sites of the bacterial protein expression plasmid pQE-31 (QIAGEN), in frame with a 5V-terminal sequence encoding six histidine residues. The resulting plasmid pQE-6H-N pro A187 was then used to transform E. coli M15 cells, and the recombinant N pro protein was expressed by induction of a log phase culture with isopropyl h-d-thiogalactopyranoside (IPTG) for 5 h at 37 -C. For protein purification by nickel chelate affinity chromatography, cells were lysed in denaturing lysis buffer (8 M Urea, 100 mM NaH 2 PO 4 , 10 mM Tris -HCl, pH 9.6) and purified using an AEKTA FPLC apparatus (Amersham Biosciences) and prepacked 1-ml HiTrap chelating columns (Amersham Biosciences), according to the manufacturer's protocol. For antiserum production, New Zealand white rabbits (Charles River Laboratories) were immunized three times at 3-week intervals with 0.5 mg purified N pro mixed 1:1 with complete Freund's adjuvant (Sigma) for the first immunization and incomplete Freund's adjuvant (Sigma) for the two booster injections. The mAb JL-8 (BD Biosciences Clontech) was used for the detection of EGFP by Western blotting. Alexa Fluor 680 goat anti-mouse and anti-rabbit IgG were obtained from Molecular Probes Inc.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting
Cellular proteins were extracted with a hypotonic buffer (20 mM morpholinepropanesulfonic acid, 10 mM NaCl, 1.5 mM MgCl 2 , 1% Triton X-100, pH 6.5). Total protein was quantified using a bicinchoninic acid-based assay (Pierce), and the concentration was adjusted to 1 mg/ml. Proteins were separated by SDS-PAGE under reducing conditions according to standard protocols (Sambrook et al., 1989) . After SDS-PAGE, gels were equilibrated for 30 min in SDS transfer buffer (12.5 mM Tris -HCl, 125 mM glycine, 0.05% SDS, 20% methanol, pH 8.3), and the proteins were transferred to a Trans-Blot nitrocellulose membrane (BioRad) in SDS transfer buffer at 15 V for 30 min using a Trans-Blot SemiDry transfer device (BioRad). The membranes were then washed briefly in PBS (80 mM Na 2 HPO 4 , 20 mM NaH 2 PO 4 , 100 mM NaCl, pH 7.3) and blocked for 1 h at room temperature or overnight at 4 -C with Odyssey Blocking Reagent (LI-COR) diluted 1:1 with PBS. For immunodetection, the membranes were incubated for 30 min at room temperature with primary and secondary antibodies diluted in Odyssey Blocking Reagent (LI-COR) mixed 1:1 with PBS. After each incubation period, the membranes were washed with PBS supplemented with 0.1% Tween 20. Two final wash steps with PBS lacking detergent were carried out prior to image acquisition and protein quantification using the Odyssey Infrared Imaging System (LI-COR).
Transfection of poly(IC)
For IFN-a/h induction, cells were transfected with poly(IC) (Sigma) using FuGENE 6 transfection reagent (Roche) according to the manufacturer's protocol. For each 5 Â 10 5 cells to be transfected, 6 Al FuGENE 6 reagent was mixed in final volume of 100 Al serum-free EMEM prior to addition of 1 Ag poly(IC), resulting in a 6 to 1 (v/w) ratio of FuGENE 6 reagent to nucleic acid. After 20 min of incubation at room temperature, the transfection mixture was added to the cells directly into the complete culture medium.
Interferon assay
Type I IFN activity was assayed as previously described (Ruggli et al., 2003) using an Mx/CAT reporter gene assay developed for the quantification of bovine IFN-a/h and kindly provided by Martin D. Fray (Institute of Animal Health, Compton, Newbury, Berkshire, UK) (Fray et al., 2001 ). This assay was validated for the detection of porcine IFN-a/h bioactivity as described elsewhere (Ruggli et al., 2003) . Briefly, MDBK-t2 cells maintained under blasticidin selection were seeded in 6-well plates at a density of 10 6 cells/well. After 24 h, samples diluted 1:5 or recombinant porcine IFN-a standard produced in HEK293-EBNA cells (Balmelli et al., 2005) was added to the cells in 1 ml EMEM supplemented with 7% heat-inactivated FCS. The cells were then incubated for 24 h prior to lysis and quantification of chloramphenicol acetyltransferase (CAT) by CAT ELISA (Roche). Infectious CSFV present in the samples was neutralized by incubation for 1 h at 4 -C with polyclonal pig anti-CSFV serum 600-88 (Ruggli et al., 1995) diluted 1:100. Virus inactivation was monitored on SK-6 cells using immunohistochemistry with mAb HC/TC26 (Greiser-Wilke et al., 1990) . Poly(IC) was removed from the samples by incubation at 37 -C for 1 h with a cocktail of 5 U/ml RNase A and 200 U/ml RNase T1 (Ambion). For neutralization of IFN-a, 250 Al of sample was incubated for 30 min on ice with 1 Al rabbit polyclonal antibody against porcine IFN-a (>250 neutralization U/Al as determined by the manufacturer, PBL Biomedical Laboratories).
Cellular RNA isolation
For IFN-h mRNA quantification, total RNA was extracted from cells using the NucleoSpin RNA II extraction kit (Macherey-Nagel). Typically, monolayers of 10 6 cells were lysed according to the manufacturer's protocol, including the DNase digestion step. The purified RNA was eluted with 60 Al RNase-free water.
Quantitative RT-PCR for porcine IFN-b mRNA
Oligonucleotides for the quantification of porcine IFN-h mRNA by TaqMan real time RT-PCR were designed based on the published porcine IFN-h coding sequence (GenBank accession nos. S41178 and M86762) (Artursson et al., 1992) using the Primer Express version 1.5 software (Applied Biosystems). The IFN-h mRNA was amplified with sense primer IFNbeta-L (5V-GGCTGGAATGAAACCGTCAT-3V) and antisense primer IFNbeta-R (5V-TCCAGGATTGTCTC-CAGGTCA-3V) in combination with the 5VFAM/3VTAMRA-labeled TaqMan probe IFNbeta-P (5V-CCTTGTGGAACTT-GATGGGCAGATGG-3V). For internal normalization with GAPDH mRNA, the sense primer porcGAPDH-F (5V-CATCACTGCCACCCAGAAGA-3V) and antisense primer porcGAPDH-R (5V-ATGATGTTCTGGGCAGCCC-3V) were used together with the 5VTET/3VTAMRA-labeled porc-GAPDH-P (5V-TGTGGATGGCCCGTCTGGGAA-3V) designed from the porcine GAPDH nucleotide sequences with GenBank accession nos. AF141959, AF202970 and U82261. Real-time RT-PCR was carried out using the TaqMan Gold RT-PCR Kit (PE Applied Biosystems). The two-step RT-PCR consisted of a reverse transcription and of a parallel control reaction in which the reverse transcriptase was omitted (no RT) followed by triplicate real-time TaqMan PCR. The 20 Al RT mixes contained RNA from approximately 10,000 cells in 1Â TaqMan Buffer A, 5.5 mM MgCl 2 , 500 AM of each dNTP, 2.5 AM random hexamers, 0.8 U/Al RNasin (Promega) and 1.25 U/Al MultiScribe reverse transcriptase and were kept for 10 min at room temperature followed by incubation at 48 -C for 30 min and enzyme inactivation at 95 -C for 10 min. Then, 4 Al of the RT reaction or of the no RT control reaction was added to the PCR mix consisting of 1Â TaqMan Buffer A, 4.5 mM MgCl 2 , 200 AM of each dNTP, 400 nM of the respective sense and antisense primer, 100 nM of the corresponding dual-labeled TaqMan probe and 0.02 U/Al AmpliTaq Gold DNA polymerase in a final volume of 25 Al. The real-time PCR was performed in a ABI PRISM 7700 Sequence Detection System (Applied Biosystems) with the following cycling profile: 10 min at 95 -C (activation of the AmpliTaq Gold DNA polymerase) followed by 50 cycles of 15 s at 95 -C and 60 s at 60 -C. The IFN-h mRNA induction was calculated by subtracting the mean C T value obtained for the RT-PCR from the C T value of the no RT control PCR (residual DNA). The individual samples were normalized to each other using the respective C T value for GAPDH mRNA.
Assay for cell survival after poly(IC) treatment
Survival of SK-6 cells to poly(IC) treatment was monitored as previously described (Ruggli et al., 2003) . Briefly, CSFV-or mock-infected SK-6 cells or stably transformed SK-6 cell clones were treated either with serial dilutions of poly(IC) (Sigma) or mock-treated. Cell survival was monitored 72 h after poly(IC) treatment by crystal violet staining. The percentage of optical density of poly(IC)-treated versus mock-treated cultures was expressed as percent cell survival.
Reporter gene assays
For the reporter gene assays, 2 Â 10 5 HEK293T cells per well of a 24-well plate were transfected with a mixture of 400 ng of inducible reporter plasmid paLuc or p125Luc, 2 ng of plasmid phRL-SV40 for internal normalization and 5 ng of the respective expression plasmid. DNA transfections were performed with FuGENE 6 transfection reagent (Roche) according to the manufacturer's protocol as described above using a 6 to 1 (v/w) FuGENE 6 to DNA ratio. Cells were incubated for 24 h at 37 -C and then transfected with 400 ng poly(IC) per well or mocktransfected as described above and incubated for additional 18 h prior to extraction and quantification of firefly and Renilla luciferase using the Dual Luciferase Reporter assay system (Promega) and a Lumat LB 9507 Luminometer with two automated injectors (Berthold Technologies).
Statistical analysis
Statistical and graphical analysis was performed using the SigmaStat and SigmaPlot software package (SPSS).
